ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DXRX Diaceutics Plc

104.00
0.00 (0.00%)
12 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Diaceutics Plc LSE:DXRX London Ordinary Share GB00BJQTGV64 ORD GBP0.002
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 104.00 103.00 105.00 104.50 104.00 104.00 10,813 08:00:22
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Testing Laboratories 19.5M 724k 0.0086 120.93 87.85M
Diaceutics Plc is listed in the Testing Laboratories sector of the London Stock Exchange with ticker DXRX. The last closing price for Diaceutics was 104p. Over the last year, Diaceutics shares have traded in a share price range of 80.50p to 109.00p.

Diaceutics currently has 84,472,431 shares in issue. The market capitalisation of Diaceutics is £87.85 million. Diaceutics has a price to earnings ratio (PE ratio) of 120.93.

Diaceutics Share Discussion Threads

Showing 126 to 150 of 150 messages
Chat Pages: 6  5  4  3  2  1
DateSubjectAuthorDiscuss
04/4/2024
15:46
Like a coiled spring.........
chrisdgb
15/3/2024
07:26
Actually, not one of those is available on Research Tree which I also use. This is my point, the notes have been made available only to corporate clients and that is down to the broker as opposed to DXRX.That said, I agree with your point, it's a crying shame that they aren't more readily accessible, but ultimately in this case with many others it's down to the brokers.
hastings
15/3/2024
06:47
Wisecat2, it is wrong to say you can't look at the research unless you pay.Like many other quoted companies the brokers covering DXRX just don't make the info readily available to private investors.It isn't something I agree with as I believe in a level playing field, but it is unfortunately still quite common. I'm fortunate enough to have seen three of the notes including the most recent initiation from Panmure, all of which make for good reading.
hastings
15/3/2024
06:38
Martin follows Filtronic. Have a look at the quality website and then look at DXRX and how cheap and out of date it is. Not good. Look at research no you cant unless you pay
not a great way to attract new shareholders. Saying that it is an interesting company but needs to help potential investors, there a lot of cheap quality companies out there

wisecat2
14/3/2024
12:55
Write up for interest, after catching up with the CEO last week.
hastings
14/2/2024
13:11
Interesting RNS.......
chrisdgb
02/2/2024
14:56
CFO here looks an interesting young chap. Nick Roberts. Left CERES to join Ergomed as number 2 to CFO just before they surged in late 2019/early 2020. Not sure when he left ERGO but has had the leg up to CFO in a smaller business. Hope his track record of picking successful companies continues here.
sevenccc
30/1/2024
07:54
All looking good, on track for my 200p+ takeout eventually......
chrisdgb
19/1/2024
08:28
Trading update in just over a week..........
chrisdgb
18/12/2023
09:42
As usual very little activity here but hoping for good things in 24'....
chrisdgb
17/11/2023
08:15
shares seem well bid at the moment.......
chrisdgb
26/9/2023
14:28
loads of potential: can it turn a decent profit?
1c3479z
26/9/2023
11:57
'accelerate the corporate development'..........could be interesting
chrisdgb
30/8/2023
11:31
Nice to see more interest here....
chrisdgb
25/8/2023
08:24
Thanks Martin...........
chrisdgb
25/8/2023
08:20
Recently caught up with management, write up for interest.
hastings
04/8/2023
09:25
Nice to see they are spreading the word, US crucial.......
chrisdgb
28/7/2023
21:35
good rise today
management and Directors very well remunerated and other benefits, altogether getting more than the annual profit presently although they would argue the company is early in its growth trajectory....

1c3479z
25/7/2023
19:42
wouldn't put it as strongly as that; there's many a company long expected to be taken over yet which has never received a bid...
DXRX value might be in the data lake they hold except ?this is the property of the large pharmas so their real value could be in their client list and lab connections.

1c3479z
25/7/2023
12:35
almost inevitable.......
chrisdgb
25/7/2023
12:23
might attract takeover interest given its strong market position, cash and connections?
1c3479z
25/7/2023
07:52
Buy it while you can.......
chrisdgb
17/7/2023
08:51
Trading update due in the coming days I would say........
chrisdgb
22/6/2023
07:47
If it stays at this price, a takeover in the next year looks inevitable........
chrisdgb
05/6/2023
08:06
Nice news.........
chrisdgb
Chat Pages: 6  5  4  3  2  1

Your Recent History

Delayed Upgrade Clock